KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Financing Activities (2019 - 2025)

Hims & Hers Health's Cash from Financing Activities history spans 7 years, with the latest figure at -$97.5 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 614.34% year-over-year to -$97.5 million; the TTM value through Dec 2025 reached $729.6 million, up 776.55%, while the annual FY2025 figure was $729.6 million, 776.55% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$97.5 million at Hims & Hers Health, down from -$39.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $889.2 million in Q2 2025 and bottomed at -$97.5 million in Q4 2025.
  • The 5-year median for Cash from Financing Activities is -$4.2 million (2021), against an average of $40.6 million.
  • The largest annual shift saw Cash from Financing Activities plummeted 13308.97% in 2022 before it surged 3647.45% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$78000.0 in 2021, then tumbled by 13308.97% to -$10.5 million in 2022, then surged by 62.11% to -$4.0 million in 2023, then plummeted by 244.49% to -$13.7 million in 2024, then tumbled by 614.34% to -$97.5 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Cash from Financing Activities are -$97.5 million (Q4 2025), -$39.0 million (Q3 2025), and $889.2 million (Q2 2025).